Title:
骨形成の疾患に作用する剤
Document Type and Number:
Japanese Patent JP3712732
Kind Code:
B2
Abstract:
PCT No. PCT/EP95/05049 Sec. 371 Date Nov. 28, 1997 Sec. 102(e) Date Nov. 28, 1997 PCT Filed Dec. 20, 1995 PCT Pub. No. WO96/23504 PCT Pub. Date Aug. 8, 1996The invention relates to an agent for the prophylaxis and/or therapy of conditions associated with a disorder of bone formation. It contains alkali metal citrates and/or alkali metal lactates and/or alkali metal malates, optionally together with one or more active substances selected from vitamin K, calcium salts and vitamin D. The agent preferably contains potassium citrates and/or sodium citrates or potassium lactates and/or sodium lactates and serves for the prophylaxis and/or therapy of osteoclasis, in particular osteoporosis or osteomalacia.
Inventors:
Dietre, Hans
Application Number:
JP52319696A
Publication Date:
November 02, 2005
Filing Date:
December 20, 1995
Export Citation:
Assignee:
Orthomol Pharmazoitische Feltripes G.M.B.H.
International Classes:
A61K31/12; A61K31/122; A61K31/19; A61K31/194; A61K31/195; A61K33/00; A61K33/06; A61K31/59; A61P19/08; A61P19/10; A61P43/00; (IPC1-7): A61K31/19; A61K31/12; A61K31/59; A61K33/00; A61K33/06; A61P19/08; A61P43/00
Domestic Patent References:
| JP4501724A | ||||
| JP2231425A | ||||
| JP5213763A |
Foreign References:
| WO1992021355A1 |
Other References:
Clinical and Experimental RHEUMATOLOGY, 1991, Vol.9, No.6,, pages 625-627
Attorney, Agent or Firm:
Masataka Oshima